Luiz Tadeu Giollo-Junior

Luiz Tadeu Giollo-Junior

Auto-generated profile, based on publicly available information

Luiz Tadeu Giollo-Junior

General Hospital at Brazilian Army, Curitiba, Parana, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
LGLuiz Tadeu Giollo-Junior
Luiz Tadeu Giollo-Junior
LCLuciana Neves Cosenso-Martin
Luciana Neves Cosenso-Martin
VLValquíria da Silva Lopes
Valquíria da Silva Lopes
MLManoel Paz Landim
Manoel Paz Landim
LFLeticia Aparecida Barufi Fernandes
Leticia Aparecida Barufi Fernandes
JVJOSE FERNANDO VILELA-MARTIN
JOSE FERNANDO VILELA-MARTIN
Resistant hypertension (RH) is characterized by being difficult to control, even with the use of various antihypertensive drugs and is associated with target organ lesions and other comorbidities. Thus, new treatment alternatives such as transcutaneous electrical nerve stimulation (TENS) can offer benefits to resistant hypertensive patients by reducing blood pressure (BP) in a non-invasive way and without the need for the association of more antihypertensive drugs. In this case, a patient with RH was submitted to three weekly applications of TENS on the stellate ganglion lasting 40 min each for 1 month. Peripheral and central hemodynamic assessments were performed by 24-h ambulatory BP monitoring (ABPM) before and after TENS applications. After completion of the TENS applications, significant reductions in office systolic (SBP) and diastolic BP (DBP) were observed. There was also a decrease in peripheral SBP and DBP in the 24‐h ABPM and sleep and SBP during wakefulness. Additionally, central parameters including central SBP and pulse wave velocity presented a significant reduction in the 24‐h ABPM, during the wakefulness and sleep. TENS is able to attenuate the sympathetic hyperactivity present in RH cases and decrease the peripheral and central hemodynamic parameters of a resistant hypertensive patient.

1 January 2022 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
AJA.P. Jarrete
A.P. Jarrete
LGL.T. Giollo-Junior
L.T. Giollo-Junior
JVJOSE FERNANDO VILELA-MARTIN
JOSE FERNANDO VILELA-MARTIN
INI.P. Novais
I.P. Novais
MDM.A. Delbin
M.A. Delbin
AZA. Zanesco
A. Zanesco
Evidence has shown that women with type 2 diabetes mellitus (T2DM) have a greater risk of cardiovascular complications compared with men, but this sex difference is not clearly understood. This study assessed the microvascular function and circulatory biomarkers in postmenopausal women (PMW) with T2DM compared with diabetic men and their non-diabetic counterparts. Sixty participants were divided into nondiabetic PMW, PMW with T2DM, non-diabetic men, and diabetic men. Microvascular function was assessed using non-invasive equipment (EndoPAT®) and reported as reactive hyperemia index (RHI). Anthropometric and cardiovascular parameters were also measured. Two-way ANOVA was performed using sex (women or men) and T2DM (non-diabetic and diabetic) as the two factors. RHI impairment (1.97±0.14) was detected in diabetic PMW compared with women without T2DM (2.5±0.13) accompanied by lower adiponectin levels (T2DM: 9.3±1.2 and CTL: 13.8±1.8 ug/mL, P<0.05). An increase in the Nε-carboxymethyllysine (CML), nitrate/nitrite, and C-reactive protein (CRP) levels were observed in diabetic PMW compared to the other groups. Although a poor glycemia control was seen in diabetic men, neither RHI nor circulatory biomarkers were affected by T2DM. Multiple linear regression stratified by sex and T2DM identified some variables with RHI only in PMW with T2DM: HbA1c (P=0.003), body mass index (P=0.029), CML (P=0.032), and CRP (P=0.006). Diabetic PMW were more susceptible to the deleterious effects of hyperglycemia than men, showing microvascular dysfunction with high levels of pro-inflammatory mediators (CML and CRP) and a lower adiponectin concentration.